EP Patent

EP3377046A1 — Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor

Assigned to Pharos Ltd · Expires 2018-09-26 · 8y expired

What this patent protects

The present invention relates to a stable pharmaceutical composition comprising a therapeutically effective quantity of a NSAID having a pulsatile release profile, such as Diclofenac or a pharmaceutically acceptable salt, prodrug, or derivative thereof, and a therapeutically effe…

USPTO Abstract

The present invention relates to a stable pharmaceutical composition comprising a therapeutically effective quantity of a NSAID having a pulsatile release profile, such as Diclofenac or a pharmaceutically acceptable salt, prodrug, or derivative thereof, and a therapeutically effective quantity of a PPI, such as Esomeprazole or a pharmaceutically acceptable salt, prodrug, or derivative thereof, in a multi-unit dosage combination, and a process for the preparation thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3377046A1
Jurisdiction
EP
Classification
—
Expires
2018-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Pharos Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.